PNLIP and obesity due to melanocortin 4 receptor deficiency: The mode of action of orlistat in the treatment of obesity is linked to its covalent binding to the serine in the active side cleft of the conserved G-X-S-X-G motif present in pancreatic lipases [21], [41].